Daily BriefsEquity Bottom-Up

Daily Brief Equity Bottom-Up: Meitetsu Transport (9077JP) Confirms Closure of Last Department Store and more

In today’s briefing:

  • Meitetsu Transport (9077JP) Confirms Closure of Last Department Store
  • Hisamitsu Pharmaceutical (4530 JP): Salonpas Holds Fort; New Products Ramp-Up; Stable FY26 Expected
  • Korea: Short Selling Data Analysis (Which Stocks Are the Gainers and the Losers?)


Meitetsu Transport (9077JP) Confirms Closure of Last Department Store

By Michael Causton

  • Until quite recently, Nagoya had seven department stores but will soon have just four. 
  • This follows Meitetsu’s decision to close its flagship store to clear the way for a major redevelopment of the station area.
  • The new development will include retail and so bring some competition to Takashimaya, which now dominates department store retailing in the city, but not before 2033.

Hisamitsu Pharmaceutical (4530 JP): Salonpas Holds Fort; New Products Ramp-Up; Stable FY26 Expected

By Tina Banerjee

  • Hisamitsu Pharmaceutical Co (4530 JP) reported double digit revenue growth in FY25 on the back of 16% YoY growth in Salonpas focused OTC pharmaceutical products.
  • Rx business revenues grew 5% YoY as Zicthoru, Apohide, Combipatch, Vivelle-Dot etc clocked healthy numbers excepting Mohrus product line.
  • Hisamitsu expects FY26 revenue to be ¥165B, up 6% YoY, driven by new products, with net profit growth to decelerate on higher cost.

Korea: Short Selling Data Analysis (Which Stocks Are the Gainers and the Losers?)

By Douglas Kim

  • We provide the short selling data analysis of the Korean stock market including the top 20 stocks in KOSPI with the highest short interest ratios in KOSPI and KOSDAQ, respectively. 
  • There have been noticeable shorting on the Ecopro Group companies and other key names in the rechargeable battery sector including Posco Future M, L&F, and SK IE Technology. 
  • Shorting has generally worked for KOSDAQ names with higher short interest ratios but not for KOSPI names in the past two weeks. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars